1091 related articles for article (PubMed ID: 15922819)
21. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
de Winter BC; Mathot RA; Sombogaard F; Neumann I; van Hest RM; Doorduijn JK; van Gelder T
Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
[TBL] [Abstract][Full Text] [Related]
22. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
Tredger JM; Brown NW; Adams J; Gonde CE; Dhawan A; Rela M; Heaton N
Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
[TBL] [Abstract][Full Text] [Related]
24. UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
van Schaik RH; van Agteren M; de Fijter JW; Hartmann A; Schmidt J; Budde K; Kuypers D; Le Meur Y; van der Werf M; Mamelok R; van Gelder T
Clin Pharmacol Ther; 2009 Sep; 86(3):319-27. PubMed ID: 19494809
[TBL] [Abstract][Full Text] [Related]
25. Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients.
Barau C; Barrail-Tran A; Hemerziu B; Habes D; Taburet AM; Debray D; Furlan V
Liver Transpl; 2011 Oct; 17(10):1152-8. PubMed ID: 21695772
[TBL] [Abstract][Full Text] [Related]
26. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
Parant F; Rivet C; Boulieu R; Gagnieu MC; Dumortier J; Boillot O; Lachaux A
Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
[TBL] [Abstract][Full Text] [Related]
27. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
Kiberd BA; Lawen J; Daley C
Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746
[TBL] [Abstract][Full Text] [Related]
28. Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.
Wigger M; Armstrong VW; Shipkova M; Wacke R; Nizze H; Streit F; von Ahsen N; Muscheites J; Glasenapp S; Stolpe HJ; Oellerich M
Ther Drug Monit; 2002 Jun; 24(3):438-43. PubMed ID: 12021639
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
[TBL] [Abstract][Full Text] [Related]
30. A clinical assessment of mycophenolate drug monitoring after liver transplantation.
Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Choi NK; Kim KW; Yu YD; Park GC; Park PJ; Choi YI
Clin Transplant; 2010; 24(2):E35-42. PubMed ID: 20070319
[TBL] [Abstract][Full Text] [Related]
31. No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients.
Kagaya H; Miura M; Satoh S; Inoue K; Saito M; Inoue T; Habuchi T; Suzuki T
J Clin Pharm Ther; 2008 Apr; 33(2):193-201. PubMed ID: 18315786
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
[TBL] [Abstract][Full Text] [Related]
33. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.
Kagaya H; Miura M; Saito M; Habuchi T; Satoh S
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):631-6. PubMed ID: 20136638
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
Dipchand AI; Pietra B; McCrindle BW; Rosebrook-Bicknell HL; Boucek MM
J Heart Lung Transplant; 2001 Oct; 20(10):1035-43. PubMed ID: 11595558
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
36. [Use of limited sampling strategy for estimating area under concentration-versus-time curve of mycophenolate sodium in renal allograft recipients].
Yang SL; Gao X; Wang QH; Zhang J; Cai JQ; Guo JQ; Tang MY; Shang LL; Tan JM
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3841-6. PubMed ID: 24548445
[TBL] [Abstract][Full Text] [Related]
37. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data.
Trkulja V; Lalić Z; Nađ-Škegro S; Lebo A; Granić P; Lovrić M; Pasini J; Božina N
Ther Drug Monit; 2014 Aug; 36(4):456-64. PubMed ID: 24518562
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.
Kamar N; Marquet P; Gandia P; Muscari F; Lavayssière L; Esposito L; Guitard J; Canivet C; Peron JM; Alric L; Suc B; Saint-Marcoux F; Rostaing L
Ther Drug Monit; 2009 Aug; 31(4):451-6. PubMed ID: 19531983
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate pharmacokinetics in early period following lung or heart transplantation.
Ensom MH; Partovi N; Decarie D; Ignaszewski AP; Fradet GJ; Levy RD
Ann Pharmacother; 2003 Dec; 37(12):1761-7. PubMed ID: 14632536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
